"10.1371_journal.pone.0151425","plos one","2016-03-29T00:00:00Z","Michael Kreuter; Svenja Ehlers-Tenenbaum; Karin Palmowski; Jacques Bruhwyler; Ute Oltmanns; Thomas Muley; Claus Peter Heussel; Arne Warth; Martin Kolb; Felix J F Herth","Centre for Interstitial and Rare Lung Diseases, Pneumology and Respiratory Critical Care Medicine, Thoraxklinik, University of Heidelberg, Heidelberg, Germany; ECSOR Department of Biostatistics, Gembloux, Belgium; Department of Translational Research, Thoraxklinik, University of Heidelberg, Heidelberg, Germany; Diagnostic and Interventional Radiology, Thoraxklinik, University of Heidelberg, Heidelberg, Germany; Department of Radiology, University of Heidelberg, Heidelberg, Germany; Institute of Pathology, University of Heidelberg, Heidelberg, Germany; McMaster University, Hamilton, ON, Canada; Member of the German Center for Lung Research, Translational Lung Research Centre, Heidelberg, Germany","Conceived and designed the experiments: M. Kreuter SET M. Kolb FH. Performed the experiments: M. Kreuter SET KP JB UO TM CPH AW M. Kolb FH. Analyzed the data: M. Kreuter SET KP JB UO TM CPH AW M. Kolb FH. Contributed reagents/materials/analysis tools: JB TM. Wrote the paper: M. Kreuter M. Kolb FH.","Michael Kreuter and his institution received grants and personal fees from InterMune, Roche and Boehringer Ingelheim. Jacques Bruhwyler was in charge of biostatistics and is employed by (CRO ECSOR, Belgium) and was financially supported by the University of Heidelberg through the unrestricted grant by InterMune / Roche. Claus Peter Heussel owns stocks from GSK and received personal fees from Boehringer, Roche, InterMune and research funding from Boehringer Ingelheim. Martin Kolb reported grants and personal fees from Roche, grants and personal fees from Boehringer Ingelheim, personal fees from GSK, personal fees from Gilead, grants from Actelion, grants from Respivert, personal fees from Astra Zeneca, personal fees from Prometic, personal fees from Genoa, outside the submitted work; Thomas Muley reported grants and non-financial support from Roche outside the submitted work. Svenja Ehlers-Tenenbaum, Karin Palmowski, Felix JF Herth and Arne Warth had nothing to disclose in relationship to this publication. Competing interests do not alter our adherence to PLOS ONE policies on sharing data and materials.","2016","03","Michael Kreuter","MK",10,TRUE,1,1,1,1,TRUE,TRUE,TRUE,6,"2;3;5;7;8;10",TRUE
